Money
Tandem Diabetes Care Adjusts Strategy for Improved Profitability and Product Launch
Tandem Diabetes Care is implementing strategic changes to enhance profitability, targeting a 65% gross margin and planning the launch of the Mobi Tubeless device in 2026.
Editorial Staff
1 min read
Tandem Diabetes Care is shifting its operational focus towards pharmacy distribution as part of a broader strategy to improve profitability.
The company has set a target of achieving a 65% gross margin by the year 2026, indicating a significant emphasis on financial performance.
Additionally, Tandem plans to introduce the Mobi Tubeless device in 2026, which may impact its product lineup and market positioning.